Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway

BACKGROUND: Esophageal cancer, especially esophageal squamous cell carcinoma (ESCC), is a common malignant tumor of the digestive tract. Bufalin is an effective anti-tumor compound. However, little is known about the regulatory mechanisms of Bufalin in ESCC. To investigate the effect and molecular m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Qianqian, Shi, Qinyan, Liu, Cheng, Fu, Guolong, Shi, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183519/
https://www.ncbi.nlm.nih.gov/pubmed/37197494
http://dx.doi.org/10.21037/jtd-23-486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183519/
https://www.ncbi.nlm.nih.gov/pubmed/37197494
http://dx.doi.org/10.21037/jtd-23-486

Ejemplares similares